rs739315
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000496.3(CRYBB2):c.54+152A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.424 in 645,064 control chromosomes in the GnomAD database, including 59,497 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.39 ( 11870 hom., cov: 33)
Exomes 𝑓: 0.44 ( 47627 hom. )
Consequence
CRYBB2
NM_000496.3 intron
NM_000496.3 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.79
Publications
8 publications found
Genes affected
CRYBB2 (HGNC:2398): (crystallin beta B2) Crystallins are separated into two classes: taxon-specific, or enzyme, and ubiquitous. The latter class constitutes the major proteins of vertebrate eye lens and maintains the transparency and refractive index of the lens. Since lens central fiber cells lose their nuclei during development, these crystallins are made and then retained throughout life, making them extremely stable proteins. Mammalian lens crystallins are divided into alpha, beta, and gamma families; beta and gamma crystallins are also considered as a superfamily. Alpha and beta families are further divided into acidic and basic groups. Seven protein regions exist in crystallins: four homologous motifs, a connecting peptide, and N- and C-terminal extensions. Beta-crystallins, the most heterogeneous, differ by the presence of the C-terminal extension (present in the basic group, none in the acidic group). Beta-crystallins form aggregates of different sizes and are able to self-associate to form dimers or to form heterodimers with other beta-crystallins. This gene, a beta basic group member, is part of a gene cluster with beta-A4, beta-B1, and beta-B3. A chain-terminating mutation was found to cause type 2 cerulean cataracts. [provided by RefSeq, Jul 2008]
CRYBB2 Gene-Disease associations (from GenCC):
- cataract 3 multiple typesInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, Laboratory for Molecular Medicine
- cataract - microcornea syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- cerulean cataractInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- early-onset nuclear cataractInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- early-onset posterior subcapsular cataractInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- early-onset sutural cataractInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- pulverulent cataractInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- total early-onset cataractInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.95).
BP6
Variant 22-25221635-A-G is Benign according to our data. Variant chr22-25221635-A-G is described in ClinVar as Benign. ClinVar VariationId is 1258808.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.439 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.389 AC: 59013AN: 151894Hom.: 11862 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
59013
AN:
151894
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.435 AC: 214661AN: 493050Hom.: 47627 AF XY: 0.437 AC XY: 114554AN XY: 262240 show subpopulations
GnomAD4 exome
AF:
AC:
214661
AN:
493050
Hom.:
AF XY:
AC XY:
114554
AN XY:
262240
show subpopulations
African (AFR)
AF:
AC:
3954
AN:
14480
American (AMR)
AF:
AC:
13717
AN:
30710
Ashkenazi Jewish (ASJ)
AF:
AC:
7169
AN:
15784
East Asian (EAS)
AF:
AC:
15595
AN:
30442
South Asian (SAS)
AF:
AC:
23632
AN:
52926
European-Finnish (FIN)
AF:
AC:
14299
AN:
32512
Middle Eastern (MID)
AF:
AC:
1423
AN:
3178
European-Non Finnish (NFE)
AF:
AC:
123112
AN:
285704
Other (OTH)
AF:
AC:
11760
AN:
27314
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.509
Heterozygous variant carriers
0
6091
12183
18274
24366
30457
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
758
1516
2274
3032
3790
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.388 AC: 59055AN: 152014Hom.: 11870 Cov.: 33 AF XY: 0.392 AC XY: 29146AN XY: 74294 show subpopulations
GnomAD4 genome
AF:
AC:
59055
AN:
152014
Hom.:
Cov.:
33
AF XY:
AC XY:
29146
AN XY:
74294
show subpopulations
African (AFR)
AF:
AC:
11484
AN:
41464
American (AMR)
AF:
AC:
6120
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
AC:
1601
AN:
3466
East Asian (EAS)
AF:
AC:
2350
AN:
5168
South Asian (SAS)
AF:
AC:
2164
AN:
4804
European-Finnish (FIN)
AF:
AC:
4658
AN:
10558
Middle Eastern (MID)
AF:
AC:
126
AN:
294
European-Non Finnish (NFE)
AF:
AC:
29268
AN:
67948
Other (OTH)
AF:
AC:
897
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1857
3714
5572
7429
9286
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
576
1152
1728
2304
2880
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1643
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jun 28, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.